BiVictriX Therapeutics

United Kingdom
Alderley Edge, England, United Kingdom, SK10 4TG

Company profile

BiVictriX Therapeutics company profile

BiVictriX is a drug discovery and development company. Their services include oncology, haematological malignancies, bispecific ADC therapeutics, biotherapeutics, immunotherapy, antibody research, and drug development.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2016-01-01, Year

Headquarters

Postal code
SK10 4TG
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Last funding
Grant / $473,320 / 2024-06-06
Last equity funding
Series Unknown
Investors
4
Lead investors
4
Founders
1
Articles
14
Exited on
2021-08-11

Founders and investors

Founders

Tiffany Thorn

Lead investors

Alderley Park VenturesDevelopment Bank of WalesInnovate UKO2h Ventures

Investors

Alderley Park VenturesDevelopment Bank of WalesInnovate UKO2h Ventures